Nanobiotix (NBTX) Non-Current Debt (2018 - 2025)

Nanobiotix (NBTX) has 8 years of Non-Current Debt data on file, last reported at $105.9 million in Q4 2025.

• In Q4 2025, Non-Current Debt rose 115.62% year-over-year to $105.9 million; the TTM figure through Dec 2025 stood at $105.9 million (up 115.62% YoY), while the FY2025 annual figure was $102.8 million, up 106.62% from the prior year.
• Non-Current Debt grew to $105.9 million in Q4 2025, from $49.1 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $105.9 million in Q4 2025 and bottomed at $28.1 million in Q4 2022.
• A 5-year average of $55.1 million and a median of $49.0 million in 2023 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2022 — Non-Current Debt tumbled 35.14% — and 2025, when it jumped 115.62%.
• Year by year, Non-Current Debt stood at $43.3 million in 2021, then slumped by 35.14% to $28.1 million in 2022, then surged by 74.65% to $49.0 million in 2023, then rose by 0.27% to $49.1 million in 2024, then jumped by 115.62% to $105.9 million in 2025.
• The last three Non-Current Debt figures came in at $105.9 million (Q4 2025), $49.1 million (Q4 2024), and $49.0 million (Q4 2023), per Business Quant data.

Peer Comparison